Shortage of plasma-derived products: a looming crisis?

被引：21
|
作者：
Li Covington, Mischa [1 ]
Voma, Chesinta [2 ]
Stowell, Sean R. [1 ,2 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Joint Program Transfus Med, Dept Pathol, 630E New Res Bldg, Boston, MA 02115 USA
[2] Qualtex Labs, Norcross, GA USA
来源：
BLOOD | 2022年 / 139卷 / 21期
关键词：
RANDOMIZED-TRIAL; FACTOR-VIII; BLOOD; FREQUENCY;
D O I：
10.1182/blood.2021015370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3222 / 3225
页数：4
相关论文
共 50 条
  • [41] Plasma-derived and recombinant FVIII
    Herzog, Roland W.
    BLOOD, 2009, 114 (04) : 753 - 754
  • [42] Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease
    Josephson, CD
    Abshire, TC
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (01) : 35 - 49
  • [43] Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better
    Mannucci, Pier Mannuccio
    BLOOD TRANSFUSION, 2010, 8 (04) : 288 - 291
  • [44] Plasma-derived medicinal products self-sufficiency from national plasma: to what extent?
    De Angelis, Vincenzo
    Breda, Antonio
    BLOOD TRANSFUSION, 2013, 11 : S132 - S137
  • [45] The Dublin Consensus Statement 2012 on optimised supply of plasma-derived medicinal products
    O'Mahony, Brian
    BLOOD TRANSFUSION, 2013, 11 (04) : 623 - 626
  • [46] Inactivation and removal of Zika virus during manufacture of plasma-derived medicinal products
    Bluemel, Johannes
    Musso, Didier
    Teitz, Sebastian
    Miyabayashi, Tomoyuki
    Boller, Klaus
    Schnierle, Barbara S.
    Baylis, Sally A.
    TRANSFUSION, 2017, 57 (03) : 790 - 796
  • [47] Biochemical and immunochemical investigations of different plasma-derived and recombinant factor VIII products
    Josic, D
    Stadler, M
    Buchacher, A
    Schulz, P
    Schutz, R
    Wiry, G
    Schwinn, H
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2095 - P2095
  • [48] Risk of hepatitis A virus infection in persons with hemophilia receiving plasma-derived products
    Richardson, LC
    Evatt, BL
    TRANSFUSION MEDICINE REVIEWS, 2000, 14 (01) : 64 - 73
  • [49] Viral Safety of Human Plasma-Derived Medicinal Products: Impact of Regulation Requirements
    Velthove, Karin J.
    Over, Jan
    Abbink, Kristiena
    Janssen, Mart P.
    TRANSFUSION MEDICINE REVIEWS, 2013, 27 (03) : 179 - 183
  • [50] Use and Future Investigations of Recombinant and Plasma-Derived Coagulation and Anticoagulant Products in the Neonate
    Punzalan, Rowena C.
    Gottschall, Jerome L.
    TRANSFUSION MEDICINE REVIEWS, 2016, 30 (04) : 189 - 196
12345